Vice President, Medical & Scientific Relations, Alzheimer’s Association
Dr. Carrillo is Vice President, Medical and Scientific Affairs, at the Alzheimer’s Association. At the Association, Dr. Carrillo has a wide range of responsibilities, including oversight of the Association’s granting process and communication of scientific findings within and outside of the organization. Dr. Carrillo is responsible for overseeing the International Research Grant Program, the mechanism through which the Association funds research. In addition to ensuring the smooth review of applications and distribution of awards to successful applicants, she is responsible for sharing results and ongoing investigations with a wide range of constituents.
Dr. Carrillo also manages several Association initiatives. One of these is the Alzheimer’s Association Research Roundtable, which provides a forum for pharmaceutical companies to discuss trends in Alzheimer research and therapeutic targets. Other Association programs managed by Dr. Carrillo include the management of the World-Wide Alzheimer’s Disease Neuroimaging Initiative (WW-ADNI), which is a multi-country research effort aimed at finding biomarkers for early detection of Alzheimer’s, and the Working Group on Technology (WGT),which aims to promote the use of technologies available today for the support of individuals affected by Alzheimer’s disease to retain their independence as long as possible.
Dr. Carrillo is a member of the Genworth Financial Medical Advisory Board.
Dr. Carrillo received her Ph.D. from Northwestern University’s Institute for Neuroscience in 1996. Since graduating from Northwestern, she completed a postdoctoral fellowship in the Division of Neurological Sciences at Rush University Medical Center in Chicago, where she later took a position as an assistant professor.
The Alzheimer’s Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s.